Pediatric cancer AI predictions are transforming how we approach treatment and monitoring in young patients, especially those with brain tumors like gliomas.A groundbreaking study from Mass General Brigham has revealed that artificial intelligence can dramatically enhance relapse risk assessment compared to traditional methods.